ArticleMicrobiology spectrum2026
Efficacy of a chemiluminescence-based urinary LAM (AIMLAM) assay in the diagnosis of active TB in Chinese children.
Article in Microbiology spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Child-friendly triage tests that do not rely on sputum for diagnosing active tuberculosis (ATB) in children are urgently required. This study aimed to assess a chemiluminescence-based urinary lipoarabinomannan test (AIMLAM) for diagnosing tuberculosis (TB) in children in China. Among the 579 children enrolled, 331 had TB, 169 had infectious diseases, and 79 were healthy controls. The area under the ROC curve of the AIMLAM test for distinguishing TB from non-TB (children with infectious diseases and healthy controls) was 0.74 (95% confidence interval [CI], 0.70-0.78), with a sensitivity of 52.2% (95% CI, 46.6%-57.6%) and a specificity of 91.9% (95% CI, 87.6%-94.9%). In 288 children with clinically diagnosed TB, the sensitivity of the test was 50.0% (95% CI, 44.1%-55.9%). LAM concentrations in extrapulmonary TB were significantly higher than those in pulmonary TB ( IMPORTANCE: This study of a large-sample cohort of children in China assessed the diagnostic accuracy of the AIMLAM test kit as an auxiliary tool for childhood TB, and to determine an age-specific reference interval for LAM concentrations in children. Our findings showed that the overall sensitivity of AIMLAM was moderate, whereas a higher sensitivity was observed in patients with bacteriologically confirmed and severe TB. Age-specific cutoff values may be needed to optimize the diagnostic model in children. These results provide preliminary evidence for a method of diagnosing ATB in pediatric patients with samples that are difficult to obtain.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.